CLINICAL_TRIALS trial_result · 2022-05-10

Clinical Trial Update: MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations [Phase 2]

Phase 2 trial update comparing targeted drugs on tumor gene variations in advanced malignant solid neoplasms; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2022-05-10